Abbott Laboratories
ABT · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $13,402 | $5,723 | $6,933 | $7,071 |
| Dep. & Amort. | $3,218 | $3,243 | $3,267 | $3,538 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $673 | $644 | $685 | $640 |
| Change in WC | -$9,217 | -$2,475 | -$1,519 | -$771 |
| Other Non-Cash | $482 | $126 | $215 | $55 |
| Operating Cash Flow | $8,558 | $7,261 | $9,581 | $10,533 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$2,207 | -$2,202 | -$1,777 | -$1,885 |
| Net Acquisitions | $1 | -$837 | $48 | -$53 |
| Inv. Purchases | -$169 | -$159 | -$185 | -$173 |
| Inv. Sales/Matur. | $28 | $43 | $152 | $77 |
| Other Inv. Act. | $9 | $22 | $22 | $26 |
| Investing Cash Flow | -$2,338 | -$3,133 | -$1,740 | -$2,008 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$537 | -$2,475 | -$699 | -$248 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | -$1,295 | -$1,227 | -$3,795 | -$2,299 |
| Dividends Paid | -$3,836 | -$3,556 | -$3,309 | -$3,202 |
| Other Fin. Act. | $264 | $167 | $167 | $255 |
| Financing Cash Flow | -$5,404 | -$7,091 | -$7,636 | -$5,494 |
| Forex Effect | -$96 | -$23 | -$122 | -$70 |
| Net Chg. in Cash | $720 | -$2,986 | $83 | $2,961 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $6,896 | $9,882 | $9,799 | $6,838 |
| End Cash | $7,616 | $6,896 | $9,882 | $9,799 |
| Free Cash Flow | $6,351 | $5,059 | $7,804 | $8,648 |